In certain embodiments, any controlled-release otic formulation described herein increases the exposure time of an active agent and decreases the C max in otic fluids (e.g., endolymph and/or perilymph) by about 40%, about 30%, about 20%, or about 10%, compared to a formulation that is not a controlled-release otic formulation
Moreover, none of the homozygous gsa2 mutants expressing any of the different transgenic GSA variants showed any visible phenotypic anomaly ( Supplementary Figure 3A )
Decreased dietary intake of these can lead to deficient glutathione formation
Quercetin: its antioxidant mechanism, antibacterial properties and potential application in prevention and control of toxipathy
In acrofacial cases, lesions primarily affect the distal fingers, facial orifices, face, hands, feet, and head